Learn All CategoriesAlzheimer’s disease(6)Article(7)Education(9)Epidermolysis Bullosa(1)events(2)Glaucoma(2)Macular Degeneration(3)presentation(4)Rare cannabinoids(5)Uncategorised(112)Webinar(3) All TagsAlzheimer’s disease(1)Article(1)videos(1) InMed Presents at Benzinga’s Healthcare and Biotech BreakthroughsJuly 2, 2024Read More Replay: InMed Presents at Emerging Growth ConferenceJune 14, 2024Read More Article: InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Degenerative DiseasesJune 14, 2024Read More Video Presentation: InMed’s INM-901 is a Potential Multi-factorial Approach to Treating Alzheimer’s DiseaseJune 12, 2024Read More The Dales Report: InMed Pharmaceuticals and Alzheimer’s ResearchMay 28, 2024Read More Drug Discovery Online Article: Cannabinoids Show Promise As New Treatment For Alzheimer’s DiseaseMay 21, 2024Read More What is Age-related Macular Degeneration? Does AMD Cause Blindness?May 21, 2024Read More InMed Presents at Webull Biotech Investment WebinarMay 16, 2024Read More Benzinga: InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer’s – New Studies Showcase INM-901’s Therapeutic AbilitiesMay 6, 2024Read More InMed presents Phase 2 clinical study results at 12th World Congress on ItchNovember 7, 2023Read More The Potential of Cannabinoids in the Treatment of Alzheimer’s DiseaseOctober 24, 2023Read More Benzinga Live Panel Discussion – Transforming the CPG Landscape: Why Rare Cannabinoids Ingredients are the Next Big ThingOctober 10, 2023Read More 12345678910111234567891011 Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP